| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.03. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy at the AACR 2024 Annual Meeting | 305 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / March 19, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs... ► Artikel lesen | |
| 11.03. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Early Safety Data from the Company's Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy Met the Study's Initial Pre-Specified Objective | 255 | ACCESSWIRE | Safety in the Phase 1b part of Sonnet's double-blind, randomized, controlled trial of SON-080 was reviewed by the study's Data Safety Monitoring Board (DSMB)The adverse event profile and tolerability... ► Artikel lesen | |
| 06.03. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.02. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers | 361 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / February 29, 2024 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for cancer, announced today... ► Artikel lesen | |
| 14.02. | Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in December - Earnings Summary | 2 | Reuters | ||
| 14.02. | Sonnet BioTherapeutics GAAP EPS of -$0.31, revenue of $18.63M | 1 | Seeking Alpha | ||
| 14.02. | Sonnet BioTherapeutics GAAP EPS of -$0.31 | 1 | Seeking Alpha | ||
| 14.02. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update | 328 | ACCESSWIRE | Successfully raised approximately $4.55 million in gross proceeds through an underwritten public offeringExtensive preclinical data on SON-1210 published in Frontiers in ImmunologyReceived approval... ► Artikel lesen | |
| 14.02. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.02. | Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quarterly Report | 6 | SEC Filings | ||
| 29.01. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 27.12.23 | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 22.12.23 | Sonnet BioTherapeutics files for $100M mixed shelf | 6 | Seeking Alpha | ||
| 21.12.23 | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy | 300 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / December 21, 2023 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for cancer, announced today... ► Artikel lesen | |
| 15.12.23 | Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in September - Earnings Summary | 4 | Reuters | ||
| 14.12.23 | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 14.12.23 | Sonnet BioTherapeutics Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 14.12.23 | Sonnet BioTherapeutics GAAP EPS of -$18.14 beats by $9.99, revenue of $0.15M in-line | 3 | Seeking Alpha | ||
| 14.12.23 | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update | 626 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / December 14, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 4.054 |
| TESLA | 3.429 |
| DEUTSCHE BANK | 2.554 |
| NEL | 1.890 |
| BYD | 1.774 |
| NVIDIA | 1.440 |
| BAYER | 1.287 |
| TUI | 1.287 |
| SUPER MICRO COMPUTER | 1.094 |
| RHEINMETALL | 997 |
| AIXTRON SE | 907 |
| COMMERZBANK | 833 |
| PHILIPS | 785 |
| MERCEDES-BENZ | 778 |
| BASF | 768 |
| RWE | 744 |
| JINKOSOLAR | 703 |
| AMAZON | 673 |
| META PLATFORMS | 673 |
| PLUG POWER | 657 |
| THYSSENKRUPP | 646 |
| DELIVERY HERO | 624 |
| HEIDELBERGER DRUCK | 613 |
| SIEMENS ENERGY | 586 |
| DEUTSCHE LUFTHANSA | 584 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
